3.5 Years of Insulin Therapy With Insulin Glargine Improves In Vivo Endothelial Function in Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2004-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000113817.48983.c5PMID 14684428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Glargine

  2012cited by this paper
• Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes.

  2003cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes

  2002cited by this paper
• Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.

  2001cited by this paper
• Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease.

  2001cited by this paper
• Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

  2001cited by this paper
• Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease

  2001cited by this paper
• Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients

  2001cited by this paper
• Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I.

  2001cited by this paper
• Insulin glargine.

  2000cited by this paper
• Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

  2000cited by this paper
• Insulin therapy improves endothelial function in type 2 diabetes.

  2000cited by this paper
• Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin.

  2000cited by this paper
• Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.

  2000cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Endothelial dysfunction in men with small LDL particles.

  2000cited by this paper
• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

  2000cited by this paper
• Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction.

  2000cited by this paper
• Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• IGF-I increases forearm blood flow without increasing forearm glucose uptake.

  1998cited by this paper
• Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Optimization of Glycemic Control by Insulin Therapy Decreases the Proportion of Small Dense LDL Particles in Diabetic Patients

  1997cited by this paper
• Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects

  1996cited by this paper
• Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.

  1996cited by this paper
• Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.

  1995cited by this paper
• Positively charged side chains in the insulin-like growth factor-1 C- and D-regions determine receptor binding specificity.

  1994cited by this paper
• Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources.

  1991cited by this paper
• Bedtime Insulin for Suppression of Overnight Free–Fatty Acid, Blood Glucose, and Glucose Production in NIDDM

  1989cited by this paper
• Insulin Therapy Induces Antiatherogenic Changes of Serum Lipoproteins in Noninsulin‐Dependent Diabetes

  1988cited by this paper

• The Modern Role of Basal Insulin in Advancing Therapy in People With Type 2 Diabetes

  2025cites this paper
• Use of lipid ratios to predict vascular target organ damage in youth.

  2024cites this paper
• Impaired vascular relaxation in type 2 diabetes: A systematic review and meta-analysis

  2024cites this paper
• Vascular nitric oxide resistance in type 2 diabetes

  2023cites this paper
• Vascular Aging: Assessment and Intervention

  2023cites this paper
• Correlation between the Outcome of Vitrectomy for Proliferative Diabetic Retinopathy and Erythrocyte Hematocrit Level and Platelet Function

  2022cites this paper
• Role of endothelial cells in vascular calcification

  2022cites this paper
• Vascular effects following intensification of glycemic control in poorly controlled patients with long-standing type 2 diabetes mellitus

  2021cites this paper
• Modulation of Small Artery Function by Insulin in Young Women: Role of Adiposity.

  2020cites this paper
• Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling

  2020cites this paper
• Léčba inzulinem a kardiovaskulární komplikace Insulin therapy and cardiovascular complications

  2018cites this paper
• Early Insulin Glargine Initiation in Iranian People With Uncontrolled Type 2 Diabetes: Glycemic Control, and Adverse Events

  2018cites this paper
• Effects of exenatide versus insulin glargine on body composition in overweight and obese T2DM patients: a randomized controlled trial

  2018cites this paper
• The Effect of Cardiovascular Risk Factors on the Coronary Circulation

  2017cites this paper
• Insulin Resistance in Type 2 Diabetes

  2016cites this paper
• Treating coronary disease and the impact of endothelial dysfunction.

  2015cites this paper
• Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers.

  2014cites this paper
• Инсулин гларгин: фармакокинетические и фармакодинамические основы клинического эффекта

  2014cites this paper
• Managing Cardiovascular Complications in Diabetes: Betteridge/Managing Cardiovascular Complications in Diabetes

  2014cites this paper
• Endothelial Dysfunction and Dyslipidemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy

  2014cites this paper
• Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect

  2014cites this paper
• The Vascular Endothelium in Diabetes

  2014cites this paper
• Managing Cardiovascular Complications in Diabetes Normal Endothelial Cell Function

  2014cites this paper
• Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events

  2013cites this paper
• Effect of Insulin Glargine and n-3 FA on Carotid Intima-Media Thickness in PeopleWithDysglycemiaatHighRiskfor Cardiovascular Events The Glucose Reduction and Atherosclerosis Continuing Evaluation Study ( ORIGIN-GRACE )

  2013cites this paper
• Effects of Exercise Training on Arterial Function in Type 2 Diabetes Mellitus

  2013cites this paper
• Insulin receptor and IGF-I receptor Bioactivity in Health and Disease

  2013cites this paper
• Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis

  2013cites this paper
• Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

  2013cites this paper
• How Do We Continue Treatment in Patients With Type 2 Diabetes When Therapeutic Goals Are Not Reached With Oral Antidiabetes Agents and Lifestyle? Incretin versus insulin treatment

  2013cites this paper
• Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: A report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study

  2012cites this paper
• Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly

  2012cites this paper
• Endothelial Dysfunction and Diabetes: Effects on Angiogenesis, Vascular Remodeling, and Wound Healing

  2012cites this paper
• Regulation and Maintenance of Vascular Tone and Patency in Cardiovascular Health and Disease

  2012cites this paper
• Basal insulin and cardiovascular and other outcomes in dysglycemia.

  2012cites this paper
• Endothelial Dysfunction and Therapeutic Intervention in Type 2 Diabetes

  2011influential citation
• Pivotal Role of Timely Basal Insulin Replacement After Metformin Failure in Sustaining Long-Term Blood Glucose Control at a Target in Type 2 Diabetes

  2011cites this paper
• Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin

  2011cites this paper
• Insulin Resistance in Type 2 Diabetes

  2010cites this paper
• Postprocedure Administration of Insulin in Canine Autologous Vein Grafting: A Potential Strategy to Attenuate Intimal Hyperplasia

  2010cites this paper
• Insulin Therapy does not Interfere with Venous Endothelial Function Evaluation in Patients with Type 2 Diabetes Mellitus

  2010cites this paper
• Microalbuminuria is associated with impaired arterial and venous endothelium-dependent vasodilation in patients with Type 2 diabetes

  2010cites this paper
• Molecular mechanisms of hyperglycemia and cardiovascular-related events in critically ill patients: rationale for the clinical benefits of insulin therapy

  2010cites this paper
• Impact of previous insulin therapy on the prognosis of diabetic patients with acute coronary syndromes.

  2010cites this paper
• Vascular Disease in the Metabolic Syndrome: Do We Need to Target the Microcirculation to Treat Large Vessel Disease?

  2009cites this paper
• Endothelial dysfunction and cardiovascular risk factors.

  2009cites this paper
• Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress

  2009cites this paper
• Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.

  2009cites this paper
• Disturbances in myocardial diastolic and vascular function with the emphasis on type 2 diabetes : Diagnostic and therapeutic opportunities

  2009cites this paper
• Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention).

  2008cites this paper
• Harnessing endocrine physiology for better clinical outcomes

  2008cites this paper
• Optimizing Antidiabetic Treatment Options for Patients with Type 2 Diabetes Mellitus and Cardiovascular Comorbidities

  2008cites this paper
• Use of Insulin to Improve Glycemic Control in Diabetes Mellitus

  2008cites this paper
• Effects of insulin resistance on endothelial function: possible mechanisms and clinical implications

  2008cites this paper
• La terapia insulinica nel diabete mellito di Tipo 2

  2008cites this paper
• Insulin Stimulates the Clonogenic Potential of Angiogenic Endothelial Progenitor Cells by IGF-1 Receptor-Dependent Signaling

  2008cites this paper
• Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus

  2007cites this paper
• Endothelial dysfunction in diabetes mellitus

  2007cites this paper
• Achieving Glycemic Goals in Type 2 Diabetes

  2007cites this paper
• Interactions between microvascular and macrovascular disease in diabetes: pathophysiology and therapeutic implications

  2007cites this paper
• Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?

  2007cites this paper
• Improvement in coronary vascular dysfunction produced with euglycaemic control in patients with type 2 diabetes

  2006cites this paper
• Time to abandon microalbuminuria?

  2006cites this paper
• Endothelial dysfunction in type 2 diabetes mellitus.

  2006cites this paper
• Nutrition Support and Hyperglycemia

  2006cites this paper
• Prevention of Cardiovascular Complications of the Metabolic Syndrome: Focus on Pharmacotherapy

  2006cites this paper
• Insulin Therapy, Glycemic Control, and Cardiovascular Risk Factors in Young Latin Americans with Type 2 Diabetes Mellitus

  2006cites this paper
• Type 2 diabetes mellitus: a cardiovascular perspective

  2005cites this paper
• Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.

  2005cites this paper
• Insulin and its analogue glargine do not affect viability and proliferation of human coronary artery endothelial and smooth muscle cells

  2005cites this paper
• Endothelial Dysfunction in the Metabolic Syndrome

  2005cites this paper
• Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation

  2005cites this paper
• Endothelial Dysfunction: Cardiovascular Risk Factors, Therapy, and Outcome

  2005cites this paper
• Insulin therapy in type 2 diabetes: role of the long‐acting insulin glargine analogue

  2004cites this paper
• Effects of prior moderate exercise on postprandial metabolism and vascular function in lean and centrally obese men.

  2004cites this paper
• Prolonged local forearm hyperinsulinemia induces sustained enhancement of nitric oxide-dependent vasodilation in healthy subjects.

  2004cites this paper
• Vascular and Platelet Function in Insulin Resistance

  2004cites this paper